A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy

Published:2023-09 Issue: Volume:249 Page:108503
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Ashfaq Aqsa,Meineck Myriam,Pautz Andrea,Arioglu-Inan Ebru,Weinmann-Menke Julia,Michel Martin C.

Funder

Deutscher Akademischer Austauschdienst France

Deutscher Akademischer Austauschdienst

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference157 articles.

1. Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy;Abdel-Wahab;Biomedicine & Pharmacotherapy,2018

2. Role of alteration in Treg/Th17 cells’ balance in nephropathic patients with Type 2 diabetes mellitus;Abouzeid;Electronic Physician,2015

3. SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction;Ahmed;Biomedicine & Pharmacotherapy,2021

4. Empagliflozin in heart failure with a preserved ejection fraction;Anker;The New England Journal of Medicine,2021

5. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury;Aroor;Cardiovascular Diabetology,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESRRA modulation by empagliflozin mitigates diabetic tubular injury via mitochondrial restoration;Cellular Signalling;2024-10

2. Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models;Pharmaceuticals;2024-03-11

3. Canagliflozin improves fatty acid oxidation and ferroptosis of renal tubular epithelial cells via FOXA1-CPT1A axis in diabetic kidney disease;Molecular and Cellular Endocrinology;2024-03

4. Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes;PLOS ONE;2023-12-06

5. RAGE/DIAPH1 and atherosclerosis through an evolving lens: Viewing the cell from the “Inside – Out”;Atherosclerosis;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3